Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention

Ana M Bolivar,Fahriye Duzagac,Nan Deng,Laura Reyes-Uribe,Kyle Chang,Wenhui Wu,Charles M Bowen,Melissa W Taggart,Selvi Thirumurthi,Patrick M Lynch,Y Nancy You,Jesus Rodriguez-Pascual,Steven M Lipkin,Scott Kopetz,Paul Scheet,Gregory A Lizee,Alexandre Reuben,Krishna M Sinha,Eduardo Vilar,Ana M. Bolivar,Charles M. Bowen,Melissa W. Taggart,Patrick M. Lynch,Y. Nancy You,Steven M. Lipkin,Gregory A. Lizee,Krishna M. Sinha
DOI: https://doi.org/10.1053/j.gastro.2024.01.016
IF: 29.4
2024-01-01
Gastroenterology
Abstract:BACKGROUND &amp; AIMS: &lt;AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE"&gt;Lynch syndrome (LS) carriers develop mismatch repair-deficient neoplasia with high neoantigen (neoAg) rates. No detailed information on targetable neoAgs from LS precancers exists, which is crucial for vaccine development and immune-interception strategies. We report a focused somatic mutation and frameshift-neoAg landscape of microsatellite loci from colorectal polyps without malignant potential (PWOMP), precancers, and early-stage cancers in LS carriers.&lt;/AbstractText&gt;METHODS: &lt;AbstractText Label="METHODS" NlmCategory="METHODS"&gt;We generated paired whole-exome and transcriptomic sequencing data from 8 colorectal PWOMP, 41 precancers, 8 advanced precancers, and 12 early-stage cancers of 43 LS carriers. A computational pipeline was developed to predict, rank, and prioritize the top 100 detected mutated neoAgs that were validated in vitro using ELISpot and tetramer assays.&lt;/AbstractText&gt;RESULTS: &lt;AbstractText Label="RESULTS" NlmCategory="RESULTS"&gt;Mutation calling revealed &gt;10 mut/Mb in 83% of cancers, 63% of advanced precancers, and 20% of precancers. Cancers displayed an average of 616 MHC-I neoAgs/sample, 294 in advanced precancers, and 107 in precancers. No neoAgs were detected in PWOMP. A total of 65% of our top 100 predicted neoAgs were immunogenic in vitro, and were present in 92% of cancers, 50% of advanced precancers, and 29% of precancers. We observed increased levels of naïve CD8<sup>+</sup> and memory CD4<sup>+</sup> T cells in mismatch repair-deficient cancers and precancers via transcriptomics analysis.&lt;/AbstractText&gt;CONCLUSIONS: &lt;AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS"&gt;Shared frameshift-neoAgs are generated within unstable microsatellite loci at initial stages of LS carcinogenesis and can induce T-cell responses, generating opportunities for vaccine development, targeting LS precancers and early-stage cancers.&lt;/AbstractText&gt;
gastroenterology & hepatology
What problem does this paper attempt to address?